vs
Side-by-side financial comparison of Anika Therapeutics, Inc. (ANIK) and Clearfield, Inc. (CLFD). Click either name above to swap in a different company.
Clearfield, Inc. is the larger business by last-quarter revenue ($34.3M vs $29.6M, roughly 1.2× Anika Therapeutics, Inc.). On growth, Anika Therapeutics, Inc. posted the faster year-over-year revenue change (13.2% vs -3.2%). Over the past eight quarters, Anika Therapeutics, Inc.'s revenue compounded faster (-1.8% CAGR vs -3.5%).
Clearfield, Inc. is a company headquartered in Minneapolis, Minnesota. The company produces fiber optic products.
ANIK vs CLFD — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $29.6M | $34.3M |
| Net Profit | — | $-614.0K |
| Gross Margin | 64.2% | 33.2% |
| Operating Margin | 17.3% | -5.3% |
| Net Margin | — | -1.8% |
| Revenue YoY | 13.2% | -3.2% |
| Net Profit YoY | — | 67.8% |
| EPS (diluted) | $0.27 | $-0.04 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $29.6M | — | ||
| Q4 25 | $30.6M | $34.3M | ||
| Q3 25 | $27.8M | $23.4M | ||
| Q2 25 | $28.2M | $49.9M | ||
| Q1 25 | $26.2M | $47.2M | ||
| Q4 24 | $30.6M | $29.7M | ||
| Q3 24 | $29.6M | $5.6M | ||
| Q2 24 | $30.7M | $48.8M |
| Q1 26 | — | — | ||
| Q4 25 | $292.0K | $-614.0K | ||
| Q3 25 | $-2.3M | $-9.1M | ||
| Q2 25 | $-4.0M | $1.6M | ||
| Q1 25 | $-4.9M | $1.3M | ||
| Q4 24 | $-21.9M | $-1.9M | ||
| Q3 24 | $-29.9M | — | ||
| Q2 24 | $-88.0K | $-447.0K |
| Q1 26 | 64.2% | — | ||
| Q4 25 | 62.6% | 33.2% | ||
| Q3 25 | 56.0% | 53.2% | ||
| Q2 25 | 50.9% | 30.5% | ||
| Q1 25 | 56.1% | 30.1% | ||
| Q4 24 | 56.0% | 29.2% | ||
| Q3 24 | 65.7% | — | ||
| Q2 24 | 66.7% | 21.9% |
| Q1 26 | 17.3% | — | ||
| Q4 25 | 2.1% | -5.3% | ||
| Q3 25 | -11.6% | 10.3% | ||
| Q2 25 | -14.8% | 3.0% | ||
| Q1 25 | -16.4% | 0.6% | ||
| Q4 24 | -2.3% | -6.9% | ||
| Q3 24 | -0.3% | — | ||
| Q2 24 | -5.9% | -4.7% |
| Q1 26 | — | — | ||
| Q4 25 | 1.0% | -1.8% | ||
| Q3 25 | -8.4% | -38.8% | ||
| Q2 25 | -14.1% | 3.2% | ||
| Q1 25 | -18.6% | 2.8% | ||
| Q4 24 | -71.4% | -6.4% | ||
| Q3 24 | -101.2% | — | ||
| Q2 24 | -0.3% | -0.9% |
| Q1 26 | $0.27 | — | ||
| Q4 25 | $0.02 | $-0.04 | ||
| Q3 25 | $-0.16 | $-0.65 | ||
| Q2 25 | $-0.28 | $0.11 | ||
| Q1 25 | $-0.34 | $0.09 | ||
| Q4 24 | $-1.49 | $-0.13 | ||
| Q3 24 | $-2.03 | — | ||
| Q2 24 | $0.00 | $-0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $41.0M | $96.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $133.9M | $249.7M |
| Total Assets | $179.4M | $268.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $41.0M | — | ||
| Q4 25 | $81.2M | $96.4M | ||
| Q3 25 | $80.2M | $106.0M | ||
| Q2 25 | $77.1M | $117.2M | ||
| Q1 25 | $75.4M | $112.0M | ||
| Q4 24 | $79.2M | $113.0M | ||
| Q3 24 | $90.7M | $129.0M | ||
| Q2 24 | $96.6M | $123.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $2.2M | ||
| Q2 24 | — | $2.1M |
| Q1 26 | $133.9M | — | ||
| Q4 25 | $143.5M | $249.7M | ||
| Q3 25 | $146.8M | $256.2M | ||
| Q2 25 | $147.7M | $264.5M | ||
| Q1 25 | $148.4M | $265.9M | ||
| Q4 24 | $154.0M | $267.4M | ||
| Q3 24 | $179.9M | $275.8M | ||
| Q2 24 | $210.3M | $274.6M |
| Q1 26 | $179.4M | — | ||
| Q4 25 | $190.3M | $268.1M | ||
| Q3 25 | $189.4M | $306.2M | ||
| Q2 25 | $187.7M | $314.7M | ||
| Q1 25 | $190.6M | $310.9M | ||
| Q4 24 | $202.7M | $303.2M | ||
| Q3 24 | $231.4M | $315.3M | ||
| Q2 24 | $262.7M | $318.1M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.01× | ||
| Q2 24 | — | 0.01× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-1.4M |
| Free Cash FlowOCF − Capex | — | $-2.4M |
| FCF MarginFCF / Revenue | — | -7.1% |
| Capex IntensityCapex / Revenue | — | 2.9% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $4.6M | $-1.4M | ||
| Q3 25 | $6.9M | — | ||
| Q2 25 | $-189.0K | $7.9M | ||
| Q1 25 | $-130.0K | $3.0M | ||
| Q4 24 | $1.6M | $7.2M | ||
| Q3 24 | $5.0M | $22.2M | ||
| Q2 24 | $-1.1M | $4.0M |
| Q1 26 | — | — | ||
| Q4 25 | $4.0M | $-2.4M | ||
| Q3 25 | $5.0M | — | ||
| Q2 25 | $-1.7M | $7.5M | ||
| Q1 25 | $-3.0M | $654.0K | ||
| Q4 24 | $275.0K | $5.1M | ||
| Q3 24 | $3.8M | $18.2M | ||
| Q2 24 | $-4.5M | $2.8M |
| Q1 26 | — | — | ||
| Q4 25 | 13.0% | -7.1% | ||
| Q3 25 | 17.9% | — | ||
| Q2 25 | -5.9% | 15.1% | ||
| Q1 25 | -11.3% | 1.4% | ||
| Q4 24 | 0.9% | 17.1% | ||
| Q3 24 | 12.9% | 323.0% | ||
| Q2 24 | -14.6% | 5.8% |
| Q1 26 | — | — | ||
| Q4 25 | 2.1% | 2.9% | ||
| Q3 25 | 6.8% | 2.0% | ||
| Q2 25 | 5.2% | 0.8% | ||
| Q1 25 | 10.8% | 5.1% | ||
| Q4 24 | 4.3% | 7.0% | ||
| Q3 24 | 4.1% | 71.4% | ||
| Q2 24 | 11.1% | 2.5% |
| Q1 26 | — | — | ||
| Q4 25 | 15.88× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 4.93× | ||
| Q1 25 | — | 2.30× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ANIK
| OEM Channel | $17.0M | 57% |
| Commercial Channel | $12.6M | 43% |
CLFD
Segment breakdown not available.
